Cell and Gene Therapy Tools and Reagents Market Report 2024 - Driving Medical Advances Cell and Gene Therapy Tools Market to Hit 16.7 Billion by 2029
| GESOX Fund | USD 20.03 0.03 0.15% |
Slightly above 55% of Lazard Global's investor base is interested to short. The analysis of overall sentiment of trading Lazard Global Equity mutual fund suggests that many investors are impartial at this time. Lazard Global's investing sentiment can be driven by a variety of factors including economic data, Lazard Global's earnings reports, geopolitical events, and overall market trends.
Lazard |
Cell and Gene Therapy Tools and Reagents Market Cell and Gene Therapy Tools and Reagents Market Dublin, Nov. 29, 2024 -- The Cell and Gene Therapy Tools and Reagents Market report has been added to ResearchAndMarkets.coms offering.The Cell and Gene Therapy Tools and Reagents Market was valued at USD 10 billion in 2024, and is projected to reach USD 16.7 billion by 2029, rising at a CAGR of 10.80.Cell and gene therapy is emerging as an essential tool for safeguarding hu
Read at finance.yahoo.com
 |
Lazard Global Fundamental Analysis
We analyze Lazard Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lazard Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lazard Global based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Lazard Global is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Lazard Global Equity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lazard Global mutual fund to make a market-neutral strategy. Peer analysis of Lazard Global could also be used in its relative valuation, which is a method of valuing Lazard Global by comparing valuation metrics with similar companies.
Peers
Lazard Global Related Equities
| USTCX | Science Technology | 1.41 | ||||
| HTECX | Hennessy Technology | 1.38 | ||||
| DRGTX | Allianzgi Technology | 0.99 | ||||
| JAGTX | Janus Global | 0.95 | ||||
| DTEYX | Dreyfus Technology | 0.87 | ||||
| PGKCX | Pgim Jennison | 0.71 | ||||
| ROGSX | Red Oak | 0.34 |
Other Information on Investing in Lazard Mutual Fund
Lazard Global financial ratios help investors to determine whether Lazard Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lazard with respect to the benefits of owning Lazard Global security.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |